<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: People with <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> have mild, <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0008282'>unconjugated hyperbilirubinemia</z:hpo> in the absence of <z:e sem="disease" ids="C0023895" disease_type="Disease or Syndrome" abbrv="">liver disease</z:e> or overt <z:mp ids='MP_0010163'>hemolysis</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Hepatic glucuronidating activity, essential for efficient biliary excretion of <z:chebi fb="0" ids="16990">bilirubin</z:chebi>, is reduced to about 30 percent of <z:mpath ids='MPATH_458'>normal</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We sequenced the coding and promoter regions of the gene for <z:chebi fb="0" ids="16990">bilirubin</z:chebi> <z:chebi fb="15" ids="17659">UDP</z:chebi>-glucuronosyltransferase 1 (<z:chebi fb="0" ids="16990">bilirubin</z:chebi>/<z:chebi fb="0" ids="16704">uridine</z:chebi> diphosphoglucuronate-glucuronosyltransferase 1)--the only enzyme that contributes substantially to <z:chebi fb="0" ids="16990">bilirubin</z:chebi> glucuronidation--in 10 unrelated patients with <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e>, 16 members of a kindred with a history of <z:e sem="disease" ids="C0268311" disease_type="Disease or Syndrome" abbrv="">Crigler-Najjar syndrome type II</z:e>, and 55 <z:mpath ids='MPATH_458'>normal</z:mpath> subjects </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: The coding region of the gene for the enzyme was <z:mpath ids='MPATH_458'>normal</z:mpath> in the 10 patients with <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>These patients were homozygous for two extra bases (TA) in the TATAA element of the 5' promoter region of the gene (A(TA)7TAA rather than the <z:mpath ids='MPATH_458'>normal</z:mpath> A(TA)6TAA) </plain></SENT>
<SENT sid="5" pm="."><plain>The presence of the longer TATAA element resulted in the reduced expression of a reporter gene, encoding firefly luciferase, in a human <z:e sem="disease" ids="C0019204" disease_type="Neoplastic Process" abbrv="">hepatoma</z:e> cell line </plain></SENT>
<SENT sid="6" pm="."><plain>The frequency of the abnormal allele was 40 percent among the <z:mpath ids='MPATH_458'>normal</z:mpath> subjects </plain></SENT>
<SENT sid="7" pm="."><plain>The 3 men in the control group who were homozygous for the longer TATAA element had significantly higher serum <z:chebi fb="0" ids="16990">bilirubin</z:chebi> levels than the other 52 <z:mpath ids='MPATH_458'>normal</z:mpath> subjects (P = 0.009) </plain></SENT>
<SENT sid="8" pm="."><plain>Among the kindred with a history of <z:e sem="disease" ids="C0268311" disease_type="Disease or Syndrome" abbrv="">Crigler-Najjar syndrome type II</z:e>, only the six heterozygous carriers who had a longer TATAA element on the structurally <z:mpath ids='MPATH_458'>normal</z:mpath> allele had mild <z:hpo ids='HP_0002904'>hyperbilirubinemia</z:hpo>, characteristic of <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Reduced expression of <z:chebi fb="0" ids="16990">bilirubin</z:chebi> <z:chebi fb="15" ids="17659">UDP</z:chebi>-glucuronosyltransferase 1 due to an abnormality in the promoter region of the gene for this enzyme appears to be necessary for <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> but not sufficient for the complete manifestation of the syndrome </plain></SENT>
</text></document>